knsa: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, KNSA has $712,333K in assets.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Deferred tax assets	201,287	205,514
Total assets	712,333	661,150

Total shareholders' equity	535,383	495,007
Total liabilities and shareholders' equity	712,333	661,150

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30, KNSA has $712,333K in assets.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Deferred tax assets	201,287	205,514
Total assets	712,333	661,150

Total shareholders' equity	535,383	495,007
Total liabilities and shareholders' equity	712,333	661,150

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Kiniksa Pharmaceuticals International, plc (KNSA)